126 related articles for article (PubMed ID: 34094920)
1. Up-Regulation of LINC00665 Facilitates the Malignant Progression of Prostate Cancer by Epigenetically Silencing KLF2 Through EZH2 and LSD1.
Xue P; Yan M; Wang K; Gu J; Zhong B; Tu C
Front Oncol; 2021; 11():639060. PubMed ID: 34094920
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA AGAP2-AS1 exerts oncogenic properties in glioblastoma by epigenetically silencing TFPI2 through EZH2 and LSD1.
Luo W; Li X; Song Z; Zhu X; Zhao S
Aging (Albany NY); 2019 Jun; 11(11):3811-3823. PubMed ID: 31186379
[TBL] [Abstract][Full Text] [Related]
3. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer.
Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M
J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691
[TBL] [Abstract][Full Text] [Related]
4. LINC00665 enhances tumorigenicity of endometrial carcinoma by interacting with high mobility group AT-hook 1.
Cai Y; Hao M; Chang Y; Liu Y
Cancer Cell Int; 2021 Jan; 21(1):8. PubMed ID: 33407473
[TBL] [Abstract][Full Text] [Related]
5. LINC00511 promotes the progression of non-small cell lung cancer through downregulating LATS2 and KLF2 by binding to EZH2 and LSD1.
Zhu FY; Zhang SR; Wang LH; Wu WD; Zhao H
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8377-8390. PubMed ID: 31646568
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of ZEB2-AS1 inhibits cell invasion and induces apoptosis in colorectal cancer.
Wu X; Zhu H; Xie Y; Gu X; Zhang L; Huang L
J BUON; 2020; 25(1):194-201. PubMed ID: 32277632
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA LINC00665 promotes metastasis of breast cancer cells by triggering EMT.
Zhou JL; Zou L; Zhu T
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3097-3104. PubMed ID: 32271427
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of LINC00665 contributes to the progression of glioma and correlates with its MRI characteristics.
Chen W; Hong L; Hou C; Zong G; Zhang J
Am J Transl Res; 2022; 14(5):2988-3002. PubMed ID: 35702084
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of LINC00665 confers decreased cell proliferation and invasion via the miR-138-5p/E2F3 signaling pathway in NSCLC.
Wang H; Wang L; Zhang S; Xu Z; Zhang G
Biomed Pharmacother; 2020 Jul; 127():110214. PubMed ID: 32403047
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA linc00665 inhibits CDKN1C expression by binding to EZH2 and affects cisplatin sensitivity of NSCLC cells.
Yang D; Feng W; Zhuang Y; Liu J; Feng Z; Xu T; Wang W; Zhu Y; Wang Z
Mol Ther Nucleic Acids; 2021 Mar; 23():1053-1065. PubMed ID: 33664990
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of TGFBR2 expression and tumour progression in prostate cancer involve diverse hypoxia-regulated pathways.
Zhou H; Wu G; Ma X; Xiao J; Yu G; Yang C; Xu N; Zhang B; Zhou J; Ye Z; Wang Z
J Exp Clin Cancer Res; 2018 Apr; 37(1):89. PubMed ID: 29699590
[TBL] [Abstract][Full Text] [Related]
12. LncRNA UNC5B-AS1 promotes malignant progression of prostate cancer by competitive binding to caspase-9.
Tan SF; Ni JX; Xiong H
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2271-2280. PubMed ID: 32196578
[TBL] [Abstract][Full Text] [Related]
13. LINC00665 promotes Ovarian Cancer progression through regulating the miRNA-34a-5p/E2F3 axis.
Xu D; Song Q; Liu Y; Chen W; Lu L; Xu M; Fang X; Zhao W; Zhou H
J Cancer; 2021; 12(6):1755-1763. PubMed ID: 33613764
[No Abstract] [Full Text] [Related]
14. LINC00702 accelerates the progression of ovarian cancer through interacting with EZH2 to inhibit the transcription of KLF2.
Wang L; Ye TY; Wu H; Chen SY; Weng JR; Xi XW
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):201-208. PubMed ID: 31389610
[TBL] [Abstract][Full Text] [Related]
15. Long Non-Coding RNA SH3PXD2A-AS1 Promotes Cell Progression Partly Through Epigenetic Silencing P57 and KLF2 in Colorectal Cancer.
Ma Z; Peng P; Zhou J; Hui B; Ji H; Wang J; Wang K
Cell Physiol Biochem; 2018; 46(6):2197-2214. PubMed ID: 29734178
[TBL] [Abstract][Full Text] [Related]
16. LINP1 promotes the progression of cervical cancer by scaffolding EZH2, LSD1, and DNMT1 to inhibit the expression of KLF2 and PRSS8.
Wu L; Gong Y; Yan T; Zhang H
Biochem Cell Biol; 2020 Oct; 98(5):591-599. PubMed ID: 32348690
[TBL] [Abstract][Full Text] [Related]
17. The carcinogenic complex lncRNA DUXAP8/EZH2/LSD1 accelerates the proliferation, migration and invasion of colorectal cancer.
Gong A; Huang Z; Ge H; Cai Y; Yang C
J BUON; 2019; 24(5):1830-1836. PubMed ID: 31786844
[TBL] [Abstract][Full Text] [Related]
18. Conditionally replicative adenovirus carrying shRNA targeting EZH2 inhibits prostate cancer growth and invasion.
Xu SG; Yu JJ; Shi Q; Niu Q; Guo Z; Guo BY; Zhou GC; Gu X; Wu YX
Oncol Rep; 2019 Jul; 42(1):273-282. PubMed ID: 31115564
[TBL] [Abstract][Full Text] [Related]
19. The long non-coding RNA DANCR regulates the inflammatory phenotype of breast cancer cells and promotes breast cancer progression via EZH2-dependent suppression of SOCS3 transcription.
Zhang KJ; Tan XL; Guo L
Mol Oncol; 2020 Feb; 14(2):309-328. PubMed ID: 31860165
[TBL] [Abstract][Full Text] [Related]
20. CircRNA LRP6 promotes the development of osteosarcoma
Zheng S; Qian Z; Jiang F; Ge D; Tang J; Chen H; Yang J; Yao Y; Yan J; Zhao L; Li H; Yang L
Am J Transl Res; 2019; 11(7):4126-4138. PubMed ID: 31396323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]